Autophagy Lysosomal Pathway In Alzheimer'S Disease represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.
Autophagy (meaning "self-eating") is a cellular degradation process that:
- Removes damaged mitochondria (mitophagy)
- Clears protein aggregates
- Eliminates intracellular pathogens
- Maintains cellular homeostasis
In AD, autophagy-lysosomal function is impaired at multiple levels, contributing to the accumulation of amyloid-beta (Aβ) and tau aggregates.
Autophagy is initiated by the ULK1 complex and Beclin-1:
- Beclin-1 levels are reduced in AD brain
- ULK1 complex signaling is impaired
- Ampk and mTOR dysregulation affects initiation
- Aβ interferes with autophagy initiation
References:
- PMID:19211852 - Beclin-1 in AD
- PMID:20085740 - Autophagy initiation in AD
- PMID:22964582 - mTOR and autophagy in AD
Lysosomes are the final degradative compartments:
- Cathepsin activity is reduced in AD
- Lysosomal membrane permeability increases
- Lysosomal acidification is impaired
- Aβ accumulates within lysosomes
References:
4. PMID:18635956 - Lysosomal dysfunction in AD
5. PMID:24140062 - Cathepsins in AD
6. PMID:27449654 - Lysosomal permeability in neurodegeneration
Fusion requires SNARE proteins and the HOPS complex:
- Syntaxin-17 is reduced in AD
- HOPS complex components are altered
- VAMP8-mediated fusion is compromised
- Leads to autophagosome accumulation
References:
7. PMID:26296890 - SNARE proteins in autophagy
8. PMID:28988862 - Autophagosome-lysosome fusion in AD
Mitochondrial quality control is essential for neuronal survival:
- PINK1/Parkin mitophagy is impaired in AD
- Mitochondrial accumulation increases ROS
- Neuronal vulnerability to metabolic stress
- Drp1-mediated fission is dysregulated
References:
9. PMID:26804779 - Mitophagy in AD
10. PMID:29908873 - PINK1/Parkin in AD pathogenesis
11. PMID:32398465 - Mitochondrial dynamics in AD
The ER is a major site of protein folding:
- ER turnover is impaired in AD
- FAM134B and Atg40 mediate ER-phagy
- ER stress accumulates in neurons
- Contributes to protein misfolding
References:
12. PMID:29327041 - ER-phagy in neurodegeneration
13. PMID:30844256 - ER stress in AD
¶ 6. TFEB and Lysosomal Biogenesis
TFEB is the master regulator of lysosomal genes:
- TFEB nuclear translocation is reduced
- Coordinated lysosomal expression (CLEAR) network impaired
- mTOR overactivation inhibits TFEB
- Therapeutic activation shows promise
References:
14. PMID:23415231 - TFEB and autophagy
15. PMID:28609654 - TFEB activation as therapeutic strategy
flowchart TD
A[Amyloid-Beta] --> B[mTOR Overactivation] -->
A --> C[Beclin-1 Reduction] -->
B --> D[Autophagy Initiation Block] -->
C --> D
D --> E[Autophagosome Accumulation] -->
E --> F[Impaired Fusion] -->
F --> G[Lysosomal Dysfunction)
G --> H[Cathepsin Inactivity] -->
H --> I[Protein Aggregate Accumulation] -->
I --> J[Aβ Plaques] -->
I --> K[Neurofibrillary Tangles)
J --> L[Synaptic Dysfunction)
K --> L
L --> M[Neuronal Death] -->
A --> N[Mitochondrial Damage] -->
N --> O[Mitophagy Block] -->
O --> P[ROS Generation] -->
P --> M
Q[ER Stress] --> R[ER-Phagy Defect] -->
R --> I
- mTOR inhibitors: Rapamycin, everolimus
- Ampa kinase activators: AICAR
- Natural compounds: Resveratrol, curcumin
- Cathepsin activators
- TFEB overexpression
- Lysosomal acidification agents
- SNARE protein upregulation
- HOPS complex stabilization
References:
16. PMID:26051251 - Autophagy modulation in AD
17. PMID:29753890 - TFEB-based therapies for AD
18. PMID:32077654 - Autophagy-lysosome pathway as therapeutic target
Autophagy-lysosomal dysfunction is a central pathological mechanism in AD, creating a vicious cycle where impaired protein clearance leads to toxic aggregate accumulation, which further disrupts cellular degradation pathways. Enhancing autophagy represents a promising therapeutic approach.
The study of Autophagy Lysosomal Pathway In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Pickrell AM, Youle RJ, The roles of PINK1 and parkin in mitochondrial quality control in Parkinson's Disease, Neuron, 2015
- Nixon RA, The role of autophagy in neurodegenerative disease, Nature Medicine, 2013
- Ballabio A, Gieselmann V, Lysosomal disorders: from storage to cellular damage, Biochimica et Biophysica Acta, 2009
- Nixon RA, Yang DS, Lee JH, Neurodegenerative lysosomal disorders: a continuum from development to late age, Autophagy, 2008
- Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease, Journal of Neuroscience, 2008
- Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, Nixon RA, Lysosomal proteolysis and autophagy require presenilin 1, and are impaired by presenilin mutations, Cell, 2010
- Ridge PG, Kauwe JSK, Mitochondria and neurodegenerative disorders, Advances in Experimental Medicine and Biology, 2018
- Khandelwal PJ, Herman AM, Hoe JS, Pack E, JCE, Autophagy in Alzheimer's disease: a review, Pharmaceuticals, 2012
- Reddy PH, Oliver DM, Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer's Disease, Cells, 2019
- Galloway CA, Yoon Y, Mitochondrial dynamics in aging and disease, Advances in Experimental Medicine and Biology, 2015
- Kerr JS, Adriaanse BA, Mitophagy and the mitochondrial unfolded protein response in neurodegeneration and aging, Aging, 2019
- Zhang J, Li X, Li JD, The roles of TFEB in autophagy and neurodegenerative diseases, Advances in Neurobiology, 2020
- Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS, Ballabio A, A gene network regulating lysosomal biogenesis and function, Science, 2009
- Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, Sardiello M, Rubinsztein DC, Ballabio A, TFEB links autophagy to lysosomal biogenesis, Science, 2011
- Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Bjorklund A, TFEB overexpression abrogates parkinsonian features and autophagy deficits in an AAV model of Parkinson's Disease, Proceedings of the National Academy of Sciences, 2013
- Zhang X, Chen S, Song L, Tang Y, Shen Y, Jia L, Le W, MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis, Autophagy, 2014
- Medina DL, Ballabio A, Lysosomal calcium regulates autophagy, Autophagy, 2015
- [Martinez-Vicente M, Talloczy Z, Wong E, Tang G, Koga H, Vempati S, Stenger F, SCO (Goldstein LS, Brown MS, Nov 2010], J Cell Biol, 2010](https://pubmed.ncbi.nlm.nih.gov/20440072/)
🟡 Moderate Confidence
| Dimension |
Score |
| Supporting Studies |
18 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 41%